The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to ...

Hopes for millions of people with Alzheimer's could be on the horizon after a new drug that slows down the progression of the ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The Alzheimer’s Association — a Chicago-based nonprofit committed to Alzheimer’s research, care and support — shared its top ...

The Alzheimer's epidemic continues to cast a shadow over the lives of millions of people. With no effective treatment ...

Spread the loveA new Alzheimer’s treatment has shown unprecedented success in late-stage clinical trials, offering hope to ...

In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...

China is the fourth major market where Kisunla has been approved after the US, Japan, and GB. It gets the green light there ...

Dec. 19, 2024 — Phase I clinical trial of a drug was successfully completed, with promise to treat Alzheimer's and other neurodegenerative diseases. The compound, ... Study Supports New Blood ...

“Among adults, 5.4% of all prescriptions in September 2024 were for GLP-1s,” Rodriguez says. That is up from 3.5% a year ...

According to Phipps, the drugs currently available to treat Alzheimer’s have only eased the symptoms rather than stop its ...

Using these measures will assist in reducing the fall risk in persons with Alzheimer’s, but there is no guarantee. Daily ...